In Vitro Synergistic Bioactivities of Novel Raffinose-Loaded PEGylated ZnO Nanoparticles: From Infection Control to Cancer Therapy

Key Points

• The research aims to evaluate the bioactivities of raffinose-loaded PEGylated zinc oxide nanoparticles for applications in infection and cancer therapy.
• Synthesis of raffinose-loaded PEGylated ZnO nanoparticles.
• Assessment of biocompatibility and stability.
• Evaluation of synergistic effects on various pathogens and cancer cells.
• Raffinose-loaded ZnO nanoparticles showed enhanced antimicrobial activity.
• Demonstrated significant cytotoxic effects on cancer cells.
• Indicated improved stability and biocompatibility compared to non-PEGylated nanoparticles.